Synthetic tumor-derived human hypercalcemic factor exhibits parathyroid hormone-like vasorelaxation in renal arteries

Biochem Biophys Res Commun. 1987 Nov 30;149(1):227-32. doi: 10.1016/0006-291x(87)91628-7.

Abstract

Synthetic human tumor hypercalcemic factor (1-34, hHF) was compared with parathyroid hormone (human sequence, 1-34; hPTH) for vasorelaxant activity in isolated rabbit renal artery segments. The hHF exhibited a potent (IC50 = 1.3 x 10(-9) M) and profound (98%) relaxation which was significantly greater in magnitude than that obtained for hPTH (IC50 = 4.5 x 10(-9) M; maximal relaxation = 78%). The relaxations to both peptides were concentration-dependent and not associated with changes in cyclic AMP levels. These results demonstrate a parathyroid hormone-like response, independent of adenylate cyclase activation, in isolated renal arteries. Renal vasodilation may be important for the effects on renal function shared by these two peptides.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Colforsin / pharmacology
  • Cyclic AMP / metabolism
  • Humans
  • Male
  • Methoxamine / pharmacology
  • Muscle Contraction / drug effects*
  • Muscle Relaxation / drug effects*
  • Neoplasm Proteins / pharmacology*
  • Parathyroid Hormone / pharmacology*
  • Parathyroid Hormone-Related Protein*
  • Peptide Fragments / pharmacology*
  • Proteins*
  • Rabbits
  • Renal Artery / drug effects
  • Renal Artery / physiology*

Substances

  • Neoplasm Proteins
  • Parathyroid Hormone
  • Parathyroid Hormone-Related Protein
  • Peptide Fragments
  • Proteins
  • parathyroid hormone-related protein (1-34)
  • Colforsin
  • Cyclic AMP
  • Methoxamine